01/14/2026
For the first time, patients in Australia and New Zealand have access to a proven treatment for dry age-related macular degeneration.
MacuMira therapy has demonstrated a capacity to improve visual function in as little as 10 days, offering a brighter future for those affected by dry AMD.
This innovative microcurrent treatment is now available through select eye care professionals.
For more information, visit MacuMira.com or click the link in our bio.
https://macumira.com/